ACETAMINOPHEN AND CODEINE PHOSPHATE Drug Patent Profile
✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Which patents cover Acetaminophen And Codeine Phosphate, and when can generic versions of Acetaminophen And Codeine Phosphate launch?
Acetaminophen And Codeine Phosphate is a drug marketed by Teva, ACI, Actavis Mid Atlantic, Akorn, Chartwell, Chartwell Molecular, Dava Pharms Inc, Pharm Assoc, Wockhardt Bio Ag, Able, Am Therap, Amneal Pharms Ny, Aurolife Pharma Llc, Duramed Pharms Barr, Elite Labs Inc, Everylife, Eywa, Fosun Pharma, Halsey, Kv Pharm, Lederle, Mikart, Mutual Pharm, Nostrum Labs Inc, Puracap Pharm, Purepac Pharm, Rhodes Pharms, Roxane, Sandoz, Specgx Llc, Strides Pharma, Sun Pharm Inds Ltd, Superpharm, Usl Pharma, Valeant Pharm Intl, Vitarine, Warner Chilcott, Watson Labs, Watson Labs Florida, and Whiteworth Town Plsn. and is included in eighty-nine NDAs.
The generic ingredient in ACETAMINOPHEN AND CODEINE PHOSPHATE is acetaminophen; codeine phosphate. There are sixty-six drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Acetaminophen And Codeine Phosphate
A generic version of ACETAMINOPHEN AND CODEINE PHOSPHATE was approved as acetaminophen; codeine phosphate by SUN PHARM INDS LTD on December 31st, 1969.
Summary for ACETAMINOPHEN AND CODEINE PHOSPHATE
|Finished Product Suppliers / Packagers:||31|
|Raw Ingredient (Bulk) Api Vendors:||6|
|Formulation / Manufacturing:||see details|
|DailyMed Link:||ACETAMINOPHEN AND CODEINE PHOSPHATE at DailyMed|
Recent Clinical Trials for ACETAMINOPHEN AND CODEINE PHOSPHATE
Identify potential brand extensions & 505(b)(2) entrants
|Roxane Laboratories||Phase 1|
Pharmacology for ACETAMINOPHEN AND CODEINE PHOSPHATE
|Drug Class||Opioid Agonist|
|Mechanism of Action||Full Opioid Agonists|